Cytokinetics Director James Daly Receives 151-Share Award

What Happened
James M. Daly, a director of Cytokinetics, received an equity award of 151 shares of common stock on 2026-07-15. The grant is recorded at $82.62 per share for a total value of $12,476. This was an award/acquisition (code A) issued as part of the company's compensation program, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-15; Form 4 filed: 2026-07-16 (timely filing).
• Shares: 151 shares granted at $82.62 per share; total value $12,476.
• Shares owned after transaction: Not reported in the provided filing.
• Footnote: F1 — Shares granted under the Cytokinetics Equity in lieu of Cash Retainer Program; shares are fully vested at grant.
• Transaction type: Award/Grant (code A). No indication of a 10b5-1 plan, tax withholding, or sale in this filing.

Context
This is a routine compensation award to a board member and the shares were fully vested on grant, meaning Daly has immediate ownership. Such awards reflect company compensation practices rather than a direct buy/sell signal; purchases by insiders are often more informative about personal conviction.